Cases & Deals

TxCell implements two-year equity line with Société Générale

Clients TxCell SA

Jones Day advised TxCell SA, a biotech company specializing in innovative, personalized cell-based immunotherapies, in connection with the implementation of a two-year equity line with Société Générale.